{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T00:55:34Z","timestamp":1649206534002},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s00393-021-01068-2","type":"journal-article","created":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T11:03:09Z","timestamp":1630494189000},"page":"140-142","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Die chronisch inflammatorisch demyelinisierende Polyneuropathie als Differenzialdiagnose zur Polymyalgia rheumatica"],"prefix":"10.1007","volume":"81","author":[{"given":"Martin","family":"Schiller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanns-Martin","family":"Lorenz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Kick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,1]]},"reference":[{"issue":"9","key":"1068_CR1","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1136\/jnnp-2019-320314","volume":"90","author":"HC Lehmann","year":"2019","unstructured":"Lehmann\u00a0HC, Burke\u00a0D, Kuwabara\u00a0S (2019) Chronic inflammatory demyelinating polyneuropathy: update on diagnosis, immunopathogenesis and treatment. J\u00a0Neurol Neurosurg Psychiatry 90(9):981\u2013987","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"1068_CR2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1212\/WNL.0b013e3181aaea47","volume":"73","author":"RS Laughlin","year":"2009","unstructured":"Laughlin\u00a0RS, Dyck\u00a0PJ, Melton\u00a0LJ 3rd et\u00a0al (2009) Incidence and prevalence of CIDP and the association of diabetes mellitus. Neurology 73(1):39\u201345","journal-title":"Neurology"},{"issue":"5","key":"1068_CR3","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1097\/WCO.0000000000000481","volume":"30","author":"RA Lewis","year":"2017","unstructured":"Lewis\u00a0RA (2017) Chronic inflammatory demyelinating polyneuropathy. Curr Opin Neurol 30(5):508\u2013512","journal-title":"Curr Opin Neurol"},{"key":"1068_CR4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jaut.2019.04.021","volume":"102","author":"Y Rodr\u00edguez","year":"2019","unstructured":"Rodr\u00edguez\u00a0Y, Vatti\u00a0N, Ram\u00edrez-Santana\u00a0C et al (2019) Chronic inflammatory demyelinating polyneuropathy as an autoimmune disease. J\u00a0Autoimmun 102:8\u201337","journal-title":"J Autoimmun"},{"key":"1068_CR5","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/j.1749-6632.1988.tb27058.x","volume":"540","author":"HP Hartung","year":"1988","unstructured":"Hartung\u00a0HP, Heininger\u00a0K, Sch\u00e4fer\u00a0B et\u00a0al (1988) Immune mechanisms in inflammatory polyneuropathy. Ann N Y Acad Sci 540:122\u2013161","journal-title":"Ann N Y Acad Sci"},{"issue":"1\u20132","key":"1068_CR6","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jneuroim.2009.11.003","volume":"218","author":"JD L\u00fcnemann","year":"2010","unstructured":"L\u00fcnemann\u00a0JD, Tackenberg\u00a0B, Stein\u00a0A et al (2010) Dysregulated Epstein-Barr virus infection in patients with CIDP. J\u00a0Neuroimmunol 218(1\u20132):107\u2013111","journal-title":"J Neuroimmunol"},{"issue":"1\u20132","key":"1068_CR7","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jns.2005.08.013","volume":"240","author":"M Mori","year":"2006","unstructured":"Mori\u00a0M, Kuwabara\u00a0S, Nemoto\u00a0Y et\u00a0al (2006) Concomitant chronic inflammatory demyelinating polyneuropathy and myasthenia gravis following cytomegalovirus infection. J\u00a0Neurol Sci 240(1\u20132):103\u2013106","journal-title":"J Neurol Sci"},{"key":"1068_CR8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jns.2015.11.013","volume":"363","author":"A Mochan","year":"2016","unstructured":"Mochan\u00a0A, Anderson\u00a0D, Modi\u00a0G (2016) CIDP in a\u00a0HIV endemic population: a prospective case series from Johannesburg, South Africa. J\u00a0Neurol Sci 363:39\u201342","journal-title":"J Neurol Sci"},{"issue":"10","key":"1068_CR9","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/nrneurol.2017.123","volume":"13","author":"YA Rajabally","year":"2017","unstructured":"Rajabally\u00a0YA, Stettner\u00a0M, Kieseier\u00a0BC et\u00a0al (2017) CIDP and other inflammatory neuropathies in diabetes\u2014diagnosis and management. Nat Rev Neurol 13(10):599\u2013611","journal-title":"Nat Rev Neurol"},{"issue":"17","key":"1068_CR10","doi-asserted-by":"publisher","first-page":"337","DOI":"10.21037\/atm.2018.07.34","volume":"6","author":"JJ Roggenbuck","year":"2018","unstructured":"Roggenbuck\u00a0JJ, Boucraut\u00a0J, Delmont\u00a0E et al (2018) Diagnostic insights into chronic-inflammatory demyelinating polyneuropathies. Ann Transl Med 6(17):337","journal-title":"Ann Transl Med"},{"issue":"3","key":"1068_CR11","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/j.1468-1331.2009.02930.x","volume":"17","author":"PY Van den Bergh","year":"2010","unstructured":"Van den Bergh\u00a0PY, Hadden\u00a0RD, Bouche\u00a0P et\u00a0al (2010) European Federation of Neurological Societies\/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a\u00a0joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society\u2014first revision. Eur J Neurol 17(3):356\u2013363","journal-title":"Eur J Neurol"},{"issue":"2","key":"1068_CR12","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s40120-020-00190-8","volume":"9","author":"H Koike","year":"2020","unstructured":"Koike\u00a0H, Katsuno\u00a0M (2020) Pathophysiology of chronic inflammatory demyelinating polyneuropathy: insights into classification and therapeutic strategy. Neurol Ther 9(2):213\u2013227","journal-title":"Neurol Ther"},{"issue":"5","key":"1068_CR13","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1097\/WCO.0000000000000595","volume":"31","author":"PE Doneddu","year":"2018","unstructured":"Doneddu\u00a0PE, Nobile-Orazio\u00a0E (2018) Management of chronic inflammatory demyelinating polyradiculopathy. Curr Opin Neurol 31(5):511\u2013516","journal-title":"Curr Opin Neurol"},{"key":"1068_CR14","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s00393-018-0476-8","volume":"77","author":"F Buttgereit","year":"2018","unstructured":"Buttgereit\u00a0F, Brabant\u00a0T, Dinges\u00a0H et al (2018) S3-Leitlinie zur Behandlung der Polymyalgia Rheumatica. Z\u00a0Rheumatol 77:429\u2013441","journal-title":"Z Rheumatol"},{"issue":"15","key":"1068_CR15","doi-asserted-by":"publisher","first-page":"e15014","DOI":"10.1097\/MD.0000000000015014","volume":"98","author":"K Diallo","year":"2019","unstructured":"Diallo\u00a0K, Jacquet\u00a0C, Alauzet\u00a0C et\u00a0al (2019) A case report of Guillain Barr\u00e9 syndrome revealing underlying infective endocarditis due to Cardiobacterium hominis. Medicine (Baltimore) 98(15):e15014","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"1068_CR16","first-page":"e9892","volume":"12","author":"NV Gadela","year":"2020","unstructured":"Gadela\u00a0NV, Drekolias\u00a0D, Rizkallah\u00a0A et\u00a0al (2020) Infective endocarditis: a rare trigger of immunoglobulin A vasculitis in an adult. Cureus 12(8):e9892","journal-title":"Cureus"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-021-01068-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00393-021-01068-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-021-01068-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T10:18:51Z","timestamp":1646302731000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00393-021-01068-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,1]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["1068"],"URL":"https:\/\/doi.org\/10.1007\/s00393-021-01068-2","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,1]]},"assertion":[{"value":"5 July 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"M.\u00a0Schiller, H.-M.\u00a0Lorenz und W.\u00a0Kick geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}